Tilray (TSE:TLRY)
NASDAQ:TLRY
TLRY Stock Chart & Stats
C$9.45
-C$0.15(-6.87%)
At close: 4:00 PM EST
C$9.45
-C$0.15(-6.87%)
Day’s Range― - ―
52-Week RangeC$4.85 - C$32.30
Previous CloseN/A
Volume1.39M
Average Volume (3M)604.82K
Market Cap
C$824.02M
Enterprise ValueC$771.48M
Total Cash (Recent Filing)C$219.93M
Total Debt (Recent Filing)C$317.08M
Price to Earnings (P/E)―
Beta1.91
Next Earnings
Jul 29, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-18.61
Shares Outstanding119,604,225
10 Day Avg. Volume541,392
30 Day Avg. Volume604,821
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.18
Price to Sales (P/S)0.34
P/FCF Ratio-2.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$11.10Price Target Upside17.43% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)-0.46
Revenue Forecast (FY)C$1.52B
Bulls Say, Bears Say
Bulls Say
International Cannabis GrowthSustained double-digit international volume growth (medical flower +100% YoY, oil +90% YoY) diversifies revenue into higher-regulation, higher-barrier markets. This durable expansion leverages GMP operations, improves mix toward medical sales and reduces reliance on volatile domestic adult-use demand.
Distribution Scale & PartnershipsRobust distribution growth and expanded pharmacy footprint create recurring, defendable routes-to-market. Strong B2B volume and new UK distribution partnerships support predictable revenue streams, margin resilience and efficient commercialization across international markets over the medium term.
Beverage Platform ExpansionAcquisitions and licensing broaden category exposure into beverage alcohol, creating scale, cross-selling and manufacturing leverage. A diversified consumer portfolio reduces single-market risk and offers multiple cash-generation pathways as the beverage unit stabilizes and integrates over the next 12–24 months.
Bears Say
Large Net Losses & Negative FCFMaterial cumulative losses and negative free cash flow signal the company remains unprofitable and reliant on external capital. Persistent deficits erode equity, constrain reinvestment, and heighten refinancing risk if operational improvements don't sustainably convert to consistent positive cash generation.
Working-capital Driven Cash UseSeasonal inventory builds and elevated receivables are consuming cash despite underlying operational improvements. Continued working-capital pressure can undermine liquidity, force recurring financing, and amplify volatility in free cash flow as the company scales international and beverage channels.
Regulatory Uncertainty (U.S. Hemp/cannabis)Prospective regulatory shifts in the U.S. hemp/cannabis framework could curb the addressable market for hemp-derived THC beverages and related products. Long-term strategy and revenue projections hinge on unclear rules, increasing execution risk for U.S. growth and product investments until policy clarity arrives.
Tilray News
TLRY FAQ
What was Tilray’s price range in the past 12 months?
Tilray lowest stock price was C$4.85 and its highest was C$32.30 in the past 12 months.
What is Tilray’s market cap?
Tilray’s market cap is C$824.02M.
When is Tilray’s upcoming earnings report date?
Tilray’s upcoming earnings report date is Jul 29, 2026 which is in 51 days.
How were Tilray’s earnings last quarter?
Tilray released its earnings results on Apr 01, 2026. The company reported -C$0.312 earnings per share for the quarter, missing the consensus estimate of -C$0.19 by -C$0.123.
Is Tilray overvalued?
According to Wall Street analysts Tilray’s price is currently Undervalued.
Does Tilray pay dividends?
Tilray does not currently pay dividends.
What is Tilray’s EPS estimate?
Tilray’s EPS estimate is -0.01.
How many shares outstanding does Tilray have?
Tilray has 119,604,225 shares outstanding.
What happened to Tilray’s price movement after its last earnings report?
Tilray reported an EPS of -C$0.312 in its last earnings report, missing expectations of -C$0.19. Following the earnings report the stock price went down -4.571%.
Which hedge fund is a major shareholder of Tilray?
Currently, no hedge funds are holding shares in TSE:TLRY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Tilray Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$11.10 (17.43% Upside)
C$11.10 (17.43% Upside)
Blogger Sentiment
Neutral
TSE:TLRY Sentiment 50%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth C$324.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.8%
Last 30 Days ▼ 3.7%
Last 30 Days ▼ 3.7%
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Negative
20 days / 200 days
Momentum
27.25%
12-Months-Change
Fundamentals
Return on Equity
-92.82%
Trailing 12-Months
Asset Growth
-39.04%
Trailing 12-Months
Company Description
Tilray
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
TLRY Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted clear operational progress: record quarterly revenue, strong international cannabis momentum, meaningful distribution growth, completed cost-savings programs and strategic beverage partnerships/acquisition that materially expand the company’s scale. Several significant challenges remain — beverage revenue and margin pressure, input cost volatility (aluminum, fuel), working capital-related cash use, regulatory uncertainty in the U.S., and integration work for BrewDog — but management presented concrete actions (hedging, Project 420, SKU rationalization, partnerships) and a strengthened liquidity position. On balance, the positive operational and strategic developments outweigh the near-term headwinds.View all TSE:TLRY earnings summariesTLRY Stock 12 Month Forecast
Average Price Target
C$11.10
▲(17.43% Upside)
Technical Analysis
Options Prices
Currently, No data available
---